NextGen Biomed by Oxford Global

2,500+ delegates | 3 annual events | 400+ companies represented

Biologic therapies are redefining what medicine can do. But translating that potential into treatments that reach patients, reliably and at scale, demands far more than scientific innovation alone.

The complexity runs the full length of the development lifecycle, and the teams working to solve it rarely sit in the same room.

NextGen Biomed is Oxford Global's brand dedicated to changing that. We unite the R&D scientists, drug discovery and development leaders, CROs, CDMOs, solution providers, and investors advancing biologics, vaccines, and novel therapeutics, giving them the critical intelligence, emerging technology insight, and strategic partnerships they need to move faster and go further.

Our community spans proteins and antibodies, ADCs, peptides, oligonucleotides, and immunotherapies.

Through flagship conferences in London and year-round digital programming, we create the space for the interdisciplinary conversations that drive this field forward, spanning ground-breaking discovery to real-world application.

Part of Oxford Global, a trusted partner for curated content and communities in life science.